002788 鷺燕醫藥
按盤價 
8.690 +0.660 (+8.219%)
8.690 +0.660 (+8.219%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 6.273 | 12.830 | 13.243 | 12.554 | 12.780 |
| 總資產報酬率 ROA (%) | 1.600 | 3.084 | 3.170 | 3.295 | 3.350 |
| 投入資產回報率 ROIC (%) | 2.068 | 4.051 | 4.154 | 4.341 | 4.138 | 邊際利潤分析 |
| 銷售毛利率 (%) | 7.482 | 7.604 | 7.785 | 7.815 | 7.960 |
| 營業利潤率 (%) | 2.379 | 2.361 | 2.394 | 2.313 | 2.406 |
| 息稅前利潤/營業總收入 (%) | 3.380 | 3.489 | 3.525 | 3.457 | 3.490 |
| 淨利潤/營業總收入 (%) | 1.851 | 1.837 | 1.803 | 1.736 | 1.718 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 107.392 | 103.549 | 110.971 | 105.120 | 107.437 |
| 價值變動淨收益/利潤總額(%) | -3.799 | -2.590 | -1.485 | -0.514 | -0.539 |
| 營業外收支淨額/利潤總額(%) | -0.026 | 0.184 | 0.014 | 2.248 | -0.703 | 償債能力分析 |
| 流動比率 (X) | 1.178 | 1.161 | 1.174 | 1.186 | 1.220 |
| 速動比率 (X) | 0.873 | 0.840 | 0.867 | 0.862 | 0.876 |
| 資產負債率 (%) | 73.751 | 74.758 | 76.318 | 74.380 | 71.446 |
| 帶息債務/全部投入資本 (%) | 64.274 | 64.990 | 67.054 | 65.077 | -- |
| 股東權益/帶息債務 (%) | 51.739 | 50.257 | 45.453 | 49.790 | 60.756 |
| 股東權益/負債合計 (%) | 35.263 | 33.417 | 30.254 | 33.524 | 38.888 |
| 利息保障倍數 (X) | 3.377 | 3.106 | 3.118 | 3.170 | 3.171 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 100.236 | 104.071 | 100.805 | 92.155 | 0.000 |
| 存貨周轉天數 (天) | 47.394 | 50.287 | 48.377 | 47.889 | 0.000 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 30/09/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
